SUBJECT MATTER EXPERTS
Mr. Albrecht, a Subject Matter Expert for IPmetrics, is the founder and President of Albrecht Pharmaceutical Consulting, Inc. He is a resource to the pharmaceutical industry, including large manufacturers, mid-sized specialty pharmaceutical companies, and biotechnology organizations, and related industry concerns, including financial institutions, managed care and reimbursement outsourcing suppliers, and other agencies. Generally, his consulting engagements include market research, competitive intelligence, and intellectual property matters.
Mr. Albrecht regularly conducts market assessments and due diligence on pharmaceutical products in development, analyzes commercial issues for marketed products, and assists companies in developing strategic marketing plans. He has over 23 years of business and leadership experience in the pharmaceutical, biotechnology and healthcare-service industries. During that time, Mr. Albrecht has held a wide spectrum of senior-level responsibilities in business development, marketing and sales management.
Mr. Albrecht spent 14 years with Eli Lilly and Astra Pharmaceutical Products, responsible for sales and sales management, new product planning, product and marketing management, and business development. His marketing achievements include the launches of Prozac® and Toprol-XL®, each of which became top-selling products for Lilly and Astra, respectively.
Mr. Albrecht has extensive commercial pharmaceutical experience specializing in conducting due diligence for financial decisions, including assessment of revenue projections, market analysis and pipeline assessments. He also conducts qualitative market research, competitive intelligence, and pharmaceutical industry training for marketing and business development managers.
Mr. Albrecht graduated with a double major in Chemistry and English from Bucknell University in 1980 and received his MBA, with a concentration in Finance, from Duke University in 1982.